Adenosine-induced transient circulatory arrest in transvenous embolization of cerebral arteriovenous malformations.
Mohammad GhorbaniChristoph J GriessenauerChristoph WipplingerPascal JabbourMahdi Kadkhodazadeh AslFarhad RahbarianAbol Ghasem MortazaviPublished in: The neuroradiology journal (2021)
Due to advances in interventional techniques, the transvenous approach may present an effective treatment option for embolization of brain arteriovenous malformations (AVMs). Contrary to the transarterial method, the transvenous approach can only be utilized in a specific subset of patients and is not suitable as a standard procedure for all AVM lesions. While this technique can be helpful in certain patients, careful patient selection to ensure patient safety and favorable clinical outcomes is important. However, especially in high-flow AVMs, targeted deposition of embolic materials through a transvenous access can be challenging. Therefore, a temporary flow arrest may prove helpful. Transient cardiac arrest by use of adenosine has been applied in cerebrovascular surgery but is not common for endovascular embolization. Adenosine-induced arrest and systemic hypotension may be a feasible, safe method to reduce flow and help endovascular transvenous embolization of certain AVMs. Our study evaluated the efficiency and safety of adenosine-induced circulatory arrest for transvenous embolization of cerebral AVMs.
Keyphrases
- patient safety
- end stage renal disease
- high glucose
- newly diagnosed
- cell cycle
- chronic kidney disease
- ejection fraction
- diabetic rats
- cerebral ischemia
- peritoneal dialysis
- prognostic factors
- minimally invasive
- protein kinase
- multiple sclerosis
- white matter
- acute coronary syndrome
- cell proliferation
- drug delivery
- blood brain barrier
- cardiopulmonary resuscitation
- resting state
- stress induced
- radiofrequency ablation
- combination therapy
- replacement therapy